Kathleen Propert

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. ncbi Did patients with interstitial cystitis who failed to respond to initial treatment with bacillus Calmette-Guerin or placebo in a randomized clinical trial benefit from a second course of open label bacillus Calmette-Guerin?
    Kathleen Joy Propert
    Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Blockley Hall, 6th Floor, 423 Guardian Dr, Philadelphia, Pennsylvania 19104, USA
    J Urol 178:886-90. 2007
  2. ncbi Chronic proton pump inhibitor therapy and the risk of colorectal cancer
    Yu Xiao Yang
    Division of Gastroenterology, University of Pennsylvania, Philadelphia, Pennsylvania 19104 6021, USA
    Gastroenterology 133:748-54. 2007
  3. ncbi Chronic statin therapy and the risk of colorectal cancer
    Yu Xiao Yang
    Division of Gastroenterology, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
    Pharmacoepidemiol Drug Saf 17:869-76. 2008
  4. ncbi A prospective study of symptoms and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome: the National Institutes of Health Chronic Prostatitis Cohort study
    Kathleen Joy Propert
    Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 6021, USA
    J Urol 175:619-23; discussion 623. 2006
  5. ncbi Followup of patients with interstitial cystitis responsive to treatment with intravesical bacillus Calmette-Guerin or placebo
    Kathleen Joy Propert
    University of Pennsylvania, Philadelphia, Pennsylvania, USA
    J Urol 179:552-5. 2008
  6. ncbi Pitfalls in the design of clinical trials for interstitial cystitis
    Kathleen Joy Propert
    Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6021, USA
    Urology 60:742-8. 2002
  7. ncbi A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis
    Robert Mayer
    University of Rochester, Rochester, New York, USA
    J Urol 173:1186-91. 2005

Research Grants

  1. Applied Methods for Analysis of Interstitial Cystitis
    Kathleen Propert; Fiscal Year: 2004

Detail Information

Publications7

  1. ncbi Did patients with interstitial cystitis who failed to respond to initial treatment with bacillus Calmette-Guerin or placebo in a randomized clinical trial benefit from a second course of open label bacillus Calmette-Guerin?
    Kathleen Joy Propert
    Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Blockley Hall, 6th Floor, 423 Guardian Dr, Philadelphia, Pennsylvania 19104, USA
    J Urol 178:886-90. 2007
    ....
  2. ncbi Chronic proton pump inhibitor therapy and the risk of colorectal cancer
    Yu Xiao Yang
    Division of Gastroenterology, University of Pennsylvania, Philadelphia, Pennsylvania 19104 6021, USA
    Gastroenterology 133:748-54. 2007
    ....
  3. ncbi Chronic statin therapy and the risk of colorectal cancer
    Yu Xiao Yang
    Division of Gastroenterology, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
    Pharmacoepidemiol Drug Saf 17:869-76. 2008
    ..We sought to clarify whether long-term statin therapy has a chemopreventive effect on the risk of colorectal cancer (CRC) in a large, population-representative cohort...
  4. ncbi A prospective study of symptoms and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome: the National Institutes of Health Chronic Prostatitis Cohort study
    Kathleen Joy Propert
    Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 6021, USA
    J Urol 175:619-23; discussion 623. 2006
    ..We present the results of 2 years of symptom and quality of life followup of men with CP/CPPS enrolled in the CPC...
  5. ncbi Followup of patients with interstitial cystitis responsive to treatment with intravesical bacillus Calmette-Guerin or placebo
    Kathleen Joy Propert
    University of Pennsylvania, Philadelphia, Pennsylvania, USA
    J Urol 179:552-5. 2008
    ..We evaluated the longer term response in patients with interstitial cystitis who initially responded to intravesical bacillus Calmette-Guerin or placebo in a randomized clinical trial...
  6. ncbi Pitfalls in the design of clinical trials for interstitial cystitis
    Kathleen Joy Propert
    Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6021, USA
    Urology 60:742-8. 2002
  7. ncbi A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis
    Robert Mayer
    University of Rochester, Rochester, New York, USA
    J Urol 173:1186-91. 2005
    ..CONCLUSIONS: Although the BCG safety profile was acceptable, the response rate for the primary outcome was low. Effective medical treatment for patients with moderate to severe interstitial cystitis remains elusive...

Research Grants4

  1. Applied Methods for Analysis of Interstitial Cystitis
    Kathleen Propert; Fiscal Year: 2004
    ..In addition, through this project, the ICDB will be maintained and made available to external investigators interested in using the data to explore specific hypotheses related to the natural history of IC. ..